Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

The rapid evolution of artificial intelligence (AI) is reshaping the field of drug design, bringing forth advanced methodologies that hold immense promise for precision oncology. This collection ...

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Amazon Web Services has launched two new AWS Certifications to provide job-ready skills in artificial intelligence, machine learning, and generative AI. The first, AWS Certified AI Practitioner, ...

It also offers a set of design principles for generative AI workflows created on AWS, specifically highlighting the need for controlled autonomy, which is particularly relevant to AI workloads.

Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic ...

in charge of building AWS generative AI products and increasing sales pipeline. “I had the privilege of advising our biggest customers on their AI execution and serving as a key design partner ...

The funding will accelerate further development of Isomorphic’s AI drug design engine and support the company’s goal of bringing its discovered drugs to clinical trials. Isomorphic Labs was ...

The AWS Generative AI Adoption Index, which surveyed 3,739 senior IT decision makers across nine countries, reveals that 45% of organizations plan to prioritize generative AI spending over ...